Our Products

Erbium Carbonate Nanopowder

Erbium Carbonate Nanopowder

Erbium Carbonate Nanopowder
Product No NRE-5078
CAS 6067-35-2
Purity 99.9%
Formula Er2(CO3)3
APS <100 nm (can be customized)
Color Pink
Molecular Weight 514.54 g/mol
Density NA
Melting Point NA
Boiling Point NA

Erbium Carbonate Nanopowder

 Applications

Optical Amplifiers: Erbium carbonate nanopowder is widely used in optical amplifiers, especially for fiber optic communications. Erbium-doped fiber amplifiers (EDFAs) are a critical component of long-distance communication systems.

Energy Storage and Conversion

Battery Technology: Erbium-based materials can be incorporated into batteries for improved performance. Erbium carbonate nanopowder may be utilized in lithium-ion batteries or supercapacitors due to its high surface area and the unique electrochemical properties of erbium.

Solar Cells: Erbium is often used in solar cells for its ability to up-convert low-energy photons to higher energy levels, improving the efficiency of solar energy conversion. Erbium carbonate nanopowder could be used in up-conversion layers in photovoltaic cells.

Catalysis

Catalysts for Chemical Reactions: can act as a catalyst or catalyst support in various chemical reactions, including organic synthesis, hydrogenation, and dehydrogenation processes. The increased surface area of nanoparticles makes them highly effective in heterogeneous catalysis.

Environmental Catalysis: could also be used in environmental catalysis, such as pollution control (e.g., carbon dioxide reduction or nitrogen oxide removal).

Biomedical Applications

Bioimaging and Diagnostics: Due to its luminescence in the near-infrared region,  can be used in bioimaging applications. It has potential in non-invasive imaging techniques such as fluorescence imaging, magnetic resonance imaging (MRI), and positron emission tomography (PET).

Drug Delivery: Erbium carbonate nanoparticles can be engineered for drug delivery systems. Their small size and high surface area enable efficient drug loading and controlled release, making them promising for targeted therapy in cancer treatment or gene therapy.

 

error: